Psyched Wellness LTD. Advisor, Professor David Nutt to Speak at PsyTech Conference
Toronto, Ontario, October 27, 2020 – Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE:PSYC, OTC Pink: DCNPF) (the “Company” or “Psyched”) a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce that the Company is sponsoring the PsyTech conference “A Global Dialogue on the Future of Psychedelic Medicine.” The conference takes place Tuesday, October 27th and will feature talks and panels from the top names in the psychedelic medicinal space including our very own Professor David Nutt.
Professor David Nutt
David Nutt is a psychiatrist at the Edmond J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept. of Medicine, Hammersmith Hospital, Imperial College London and is the chair of the scientific advisory board for Compass Pathways. His research area is psychopharmacology – the study of the effects of drugs on the brain, from the perspectives of both how drug treatments in psychiatry and neurology work, and why people use and become addicted to some drugs such as alcohol. To study the effects of drugs in the brain he uses state-of-the-art techniques such as brain imaging with PET and fMRI plus EEG and MEG. This research output has led to over 500 original research papers and a similar number of reviews and books chapters, eight government reports on drugs and 35 books, including one for the general public, Drugs: Without the Hot Air, which won the Transmission Prize in 2014.
He was previously president of the European Brain Council, the British Association of Psychopharmacology, the British Neuroscience Association and the European College of Neuropsychopharmacology. He is currently founding chair of DrugScience.org.uk and holds visiting professorships at the Open University and University of Maastricht.
David broadcasts widely to the general public both on radio and television. In 2010, the Times Eureka science magazine voted him one of the 100 most important figures in British science, and the only psychiatrist on that list. In 2013 he was awarded the John Maddox Prize from Nature/Sense for standing up for science and in 2017 a Doctor of Laws hon causa from the University of Bath.
Jeff Stevens, Chief Executive Officer of the Company said, “We are excited to sponsor this event and support Professor Nutt, one of our key scientific advisors as he shares his experience and knowledge surrounding psychedelics at the conference. Professor Nutt has studied many of the psychedelic compounds including Amanita Muscaria so when he learned that Amanita Muscaria was the mushroom of focus for Psyched he was keen to join our team. To our knowledge, we are the only company with a strong scientific team focused on this mushroom”.